Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#PediatricHealth

Home » #PediatricHealth
IDWeek 2024 Highlights: Advancements in RSV Prevention for Children with Vaccines and Monoclonal Antibodies

IDWeek 2024 Highlights: Advancements in RSV Prevention for Children with Vaccines and Monoclonal Antibodies

Posted by By Lisa Cui 2024.11.18
Respiratory syncytial virus (RSV) continues to pose significant health risks for infants and immunocompromised individuals. At the recently concluded IDWeek 2024 in Los Angeles, pivotal studies on RSV prevention drew…
Read More
AASLD Voice of China | Dr. Hongfei Zhang’s Team: Latest Stage Data Revealed for China’s “Sprout” Project, Aiding Clinical Cure for Children with Chronic Hepatitis B

AASLD Voice of China | Dr. Hongfei Zhang’s Team: Latest Stage Data Revealed for China’s “Sprout” Project, Aiding Clinical Cure for Children with Chronic Hepatitis B

Posted by By Mourabit Halima 2024.01.18
Editor's Note: Chronic hepatitis B is the leading cause of liver disease in Chinese children, posing a serious threat to their health. The "Sprout" project is China's first large-scale real-world…
Read More
Recent Posts
  • ESMO 2026 | Professor Jiwei Huang: Exploring Personalized Treatment for Non-Clear Cell Renal Cell Carcinoma Through Targeted Therapy Plus Immunotherapy—The Clinical Rationale, Efficacy Signals, and Identification of Benefiting Patient Populations in the FRONTIER Study
  • Professor Jun Guo: Addressing Unmet Clinical Needs to Explore a New Treatment Approach for Favorable-Risk Renal Cell Carcinoma — Balancing Tumor Control with Long-Term Tolerability: The Rationale Behind Ivonescimab
  • Professor Zhenhua Liu: Exploring the Potential of PSMA-Targeted ADCs in Advanced Prostate Cancer — From Early SHR-4394 Findings and Patient Selection to Combination Therapy Strategies
  • ESMO 2026 | Professor Dingwei Ye: Enfortumab Vedotin Advances Integrated Perioperative Treatment for MIBC, Moving from Deep Responses Toward Long-Term Benefit
  • ESMO 2026 | Professor Jun Guo: Seizing the Critical First-Line Treatment Window to Achieve Deep and Durable Responses and Improve Long-Term Survival
Recent Comments
    Archives
    • November 2026
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top